NCT00397800 2012-08-28Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's LymphomaTechnical University of MunichPhase 1/2 Unknown12 enrolled